2'-Methylbiphenyl-4-carboxylic acid, 95.0%, 500mg

1H-Benzimadazole-5-carboxylic acid, 97.0%, 5g

5-(Trifluoromethyl)pyridine-2-sulfonyl chloride, 95.0%, 100mg

2-Cyano-N-(hexyl)-acetamide, 250mg

Plan PLPHi S40x/0.65 phase contrast IOS infinity corrected objective

Na-Z-Nd-Boc-D-ornithine, 99.0%, 1g

S-(2-Carboxyethyl)-L-cysteine>98.0%(T)100mg

Oxazole, 2,2'-methylenebis[4,5-dihydro-4,5-diphenyl-, (4R,4'R,5S,5'S)-, 95%, 100mg

Pentafluorophenyl trimethylsilane, 95%, 1g

[3-(Aminomethyl)oxetan-3-yl]methanol, 97.0%, 500mg

tert-Butyl 4-ethynylbenzylcarbamate, 95.0%, 5g

4-(2-Amino-ethoxymethyl)-piperidine-1-carboxylic acid tert-butyl ester, 250mg

Potassium (S)-2-aminosuccinate, 95.0%, 500g